Home › Colon Cancer › Maryland
Colon Cancer clinical trials in Maryland
24 studies for Colon Cancer are looking for participants at sites in Maryland.
Cities in Maryland
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
- University of Maryland ( Site 2016), Baltimore
- Greater Baltimore Medical Center ( Site 0068), Baltimore
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT06997497Neoadjuvant Pembrolizumab and Porustobart in Resectable pMMR/MSS Colon Cancer
- Investigator Site, Baltimore
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT07808151Genomic Services Research Program
- National Institutes of Health Clinical Center, Bethesda
RecruitingObservational study
1 Month – 105 Years · All sexes · Updated Nov 12, 2026 · NCT02595957Shield Post-Approval Study Protocol
- Olney Medical Group, Olney
RecruitingObservational studyHealthy volunteers welcome
Ages 45 to 81 · All sexes · Updated Nov 12, 2026 · NCT06880055Collection of Blood From Patients With Cancer
- National Institutes of Health Clinical Center, Bethesda
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT00034216Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
- National Institutes of Health Clinical Center, Bethesda
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT00451022Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
- National Institutes of Health Clinical Center, Bethesda
RecruitingPhase 1
Ages 18 to 120 · All sexes · Updated Nov 5, 2026 · NCT06885697Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
- UM Upper Chesapeake Hematology and Oncology - Aberdeen, Aberdeen
- Greater Baltimore Medical Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- and 14 more
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT05174169Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
- Christiana Care - Union Hospital, Elkton
RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07283939Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
- Kaiser Permanente-Woodlawn Medical Center, Baltimore
- Kaiser Permanente-Gaithersburg Medical Center, Gaithersburg
- Kaiser Permanente - Kensington Medical Center, Kensington
- and 2 more
Recruiting
Ages 45 to 70 · All sexes · Updated Nov 4, 2026 · NCT05080673Family Communications After Genetic Testing
- Sinai Hospital of Baltimore, Baltimore
- Northwest Hospital Center, Randallstown
- UM Saint Joseph Medical Center, Towson
- and 1 more
RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT07143487Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
- National Institutes of Health Clinical Center, Bethesda
RecruitingPhase 1/2
Ages 18 to 72 · All sexes · Updated Nov 3, 2026 · NCT03190941A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
- Saint Agnes Hospital, Baltimore
- Cancer Center For Blood Disorders A Division of American Oncology Partners P.A, Bethesda
- Sarah Cannon Research Institute Scri Oncology Partners, Brandywine
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 30, 2026 · NCT07284849Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Greater Baltimore Medical Center, Baltimore
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 8, 2026 · NCT07222800A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)
- University of Maryland Greenbaum, Baltimore
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 3, 2026 · NCT07058012KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer
- Sidney Kimmel Comprehensive Cancer Center, Baltimore
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT06411691EXoPERT EMERALD Clinical Study
- John Hopkins University, Baltimore
RecruitingObservational studyHealthy volunteers welcome
Ages 45 and older · All sexes · Updated Jul 1, 2026 · NCT07186296Integrated Cancer Repository for Cancer Research
- Northwest Hospital, Randallstown
- William E. Kahlert Regional Cancer Center, Westminster
RecruitingObservational studyHealthy volunteers welcome
Ages 19 to 110 · All sexes · Updated Jun 29, 2026 · NCT02012699A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)
- Maryland Oncology Hematology, Columbia
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jun 12, 2026 · NCT07011576Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
- Advanced Molecular Imaging and Therapy, Glen Burnie
- United Theranostics - Chesapeake, Glen Burnie
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jun 11, 2026 · NCT05283330Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
- Johns Hopkins University, Baltimore
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jun 3, 2026 · NCT06040541Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
- Johns Hopkins University, Baltimore
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated May 15, 2026 · NCT05379985Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
- GSK Investigational Site, Bethesda
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jan 23, 2026 · NCT05855200SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Baltimore
- Massive Bio SYNERGY-AI site, Bethesda
- Massive Bio SYNERGY-AI site, Silver Spring
- and 1 more
RecruitingObservational study
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.